HIV care · Lancet Reg Health Am · 2022
HIV trial promised hair tests and missed-appointment counts. Its paper reports neither and never says so.
Each measure’s place in the trial’s public plan and in the paper
The paper says
A trial of 360 people with HIV who had dropped out of care tested whether a doctor-led programme helps them take their drugs and stay in care. The paper cites its public plan, explains two departures from it, and concludes the programme may improve pill-taking.
Its own data show
The trial’s plan, posted on ClinicalTrials.gov (a public website for trial plans) before anyone joined, promised hair tests, which measure the HIV drug’s level, and a count of missed clinic appointments. Those promises were never edited. The paper reports no hair-test results, counts attendance at the study’s own check-ups instead, and mentions neither change.
Trials post their plan in advance so readers can check that the promised measures get reported. Attending the study’s check-ups, with $10 paid for travel, mostly shows who stayed in the study, not whether they kept clinic appointments in between. Without hair tests, the pill-taking conclusion rests only on patients’ own answers, with no drug-level measure to check them.